Jim Cramer on SentinelOne: “You Got to Stick With the High-Quality Ones”
Yahoo Finance· 2025-12-21 15:26
Core Insights - SentinelOne, Inc. (NYSE:S) reported strong financial results for Q3 FY26, with non-GAAP EPS of $0.07, exceeding estimates by $0.02, and revenue of $258.9 million, reflecting a nearly 23% year-over-year increase and beating estimates by $2.72 million [1] - The company provided guidance for Q4 FY26, expecting revenue of $271 million, a non-GAAP gross margin of 77.5%, and a non-GAAP operating margin of 5% [2] - For the full fiscal year 2026, SentinelOne anticipates revenues of $1.001 billion, a non-GAAP gross margin of 78.5%, and a non-GAAP operating margin of 3% [2] Company Positioning - Jim Cramer expressed skepticism about SentinelOne as a good investment, suggesting investors should focus on higher-quality stocks like CrowdStrike or Palo Alto Networks [1] - The company specializes in AI-powered cybersecurity solutions, protecting devices, cloud systems, and user identities from cyber threats [1]
Jim Cramer Applauds FedEx for a Strong Quarter
Yahoo Finance· 2025-12-21 15:26
FedEx Corporation (NYSE:FDX) is one of the stocks Jim Cramer offered insights on. Cramer praised the company’s latest quarterly results, as he remarked: “Look at these numbers from FedEx. After the close today, the freight powerhouse reported a truly strong quarter with higher-than-expected revenues and a 70-cent earnings beat… Even better, management raised the low end of their full-year forecast for both revenue and earnings. This company spent years trying to cut costs and optimize its delivery network ...
McKesson Stock: I Expect A Significant Slowdown In 2026 (NYSE:MCK)
Seeking Alpha· 2025-12-21 15:26
If you enjoyed this, consider Ian's Insider Corner to enjoy access to similar initiation reports for all the new stocks that we buy. Membership also includes an active chat room, weekly updates, and my responses to your questions.McKesson ( MCK ) is one of the three major pharmaceutical drug distribution companies in the United States. It, along with Cardinal Health ( CAH ) and Cencora ( COR ), has a dominant position in the market and servesIan Bezek is a former hedge fund analyst at Kerrisdale Capital. He ...
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Alexandria Real Estate Equities
Businesswire· 2025-12-21 15:20
Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Alexandria Real Estate Equities, Inc. regarding violations of federal securities laws, with a deadline for investors to seek lead plaintiff status by January 26, 2026 [1][3]. Group 1: Allegations Against Alexandria - The complaint alleges that Alexandria and its executives made false and misleading statements while failing to disclose adverse facts about the Long Island City property, particularly regarding its leasing value as a life-science destination [3]. - Alexandria's claims about the property were reportedly inconsistent with the actual state of affairs, which could mislead investors [3]. Group 2: Financial Performance - Alexandria reported third quarter earnings for 2025 that fell short of analyst expectations, with a 5% decline in revenue and a 7% decline in adjusted funds from operation [4]. - The average occupancy rate decreased from 94.8% in the previous year to 91.4% [4]. - Following the release of these disappointing financial results, Alexandria's stock price dropped over 19% on October 28, 2025 [4]. Group 3: Legal Proceedings - The lead plaintiff in the class action will be the investor with the largest financial interest who is also typical of class members, overseeing the litigation on behalf of the class [5]. - Any member of the class can apply to serve as lead plaintiff or remain an absent class member without affecting their ability to share in any recovery [5]. Group 4: Call for Information - Faruqi & Faruqi encourages individuals with information regarding Alexandria's conduct, including whistleblowers and former employees, to come forward [6].
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Sprouts Farmers Market
Businesswire· 2025-12-21 15:17
Core Insights - Sprouts Farmers Market, Inc. reported a 4.3% decrease in comparable store growth for Q3 fiscal 2025, which is below previous projections and indicates a concerning trend for the company [2] - The company has revised its full-year growth expectations down from 7.5%-9% to 7%, reflecting a continued reduction in comparable sales growth projected for Q4 at only 0%-2% [2] - Following the disappointing earnings report, Sprouts' stock price dropped by $22.64, opening at $81.91 per share [2] Company Performance - The decrease in comparable store growth is attributed to challenging year-over-year comparisons and a softening consumer market [2] - Management previously claimed resilience in performance regardless of macroeconomic conditions, highlighting a shift in narrative following the recent results [2] Legal Investigation - Faruqi & Faruqi, LLP is investigating potential claims against Sprouts Farmers Market, indicating possible legal challenges ahead for the company [1]
The 200-Year-Old Secret: Why Preferred Stock Is The Ultimate Fixed Income Hybrid
Seeking Alpha· 2025-12-21 15:15
Core Insights - Preferred shares have been utilized for over 200 years, with the Pennsylvania Railroad Company issuing perpetual preferreds at a 6% coupon in 1878 to raise capital without diluting shareholders [1] Group 1: Investment Strategy - The service led by Rida Morwa focuses on sustainable income through high-yield investments, targeting a safe +9% yield [1] - Features of the service include a model portfolio with buy/sell alerts, preferred and baby bond portfolios for conservative investors, and regular market updates [1] Group 2: Community and Education - The service emphasizes community and education, promoting the belief that investors should not invest alone [1]
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at James Hardie
Businesswire· 2025-12-21 15:15
Core Points - Faruqi & Faruqi, LLP is investigating potential claims against James Hardie Industries plc [1] - A federal securities class action has been filed against James Hardie, with a deadline of December 23, 2025, for investors to seek the role of lead plaintiff [1] Company Overview - James Hardie Industries plc is listed on the NYSE under the ticker symbol JHX [1] - The investigation is being conducted by a leading national securities law firm with offices in New York, Pennsylvania, California, and Georgia [1]
Jim Cramer Says “Oracle Stock Has Gotten Crushed as We Found Out More About That OpenAI Relationship”
Yahoo Finance· 2025-12-21 15:14
Group 1 - Oracle Corporation is involved in a significant deal with OpenAI, which is a $300 billion five-year agreement that has not been formally announced but is reflected in the remaining performance obligation line [1] - The company provides a range of services including cloud and on-premise software, databases, IT infrastructure, hardware, consulting, and support services [2] - There is a belief that while Oracle has potential as an investment, other AI stocks may offer greater upside potential and carry less downside risk [3]
Jim Cramer on Blue Owl Capital: “Discipline is Coming”
Yahoo Finance· 2025-12-21 15:14
Group 1 - Blue Owl Capital Inc. is noted for its disciplined investment approach, as highlighted by Jim Cramer, particularly in its decision to refuse a $10 billion deal for an Oracle data center in Michigan [1] - The company's refusal to engage in the deal is seen as a positive sign of rational decision-making in the face of balance sheet concerns [1] - Reports indicate that alternative financing sources are available, suggesting that Blue Owl's involvement was not essential for the Oracle project [1] Group 2 - Blue Owl Capital provides alternative asset management and private financing solutions, including direct lending, credit products, and real estate investments [2]
Jim Cramer on HCA Healthcare: “I Think It’s a Terrific One to Buy”
Yahoo Finance· 2025-12-21 15:14
Group 1 - HCA Healthcare, Inc. operates a network of 190 hospitals and approximately 2,400 ambulatory care sites, with a significant reduction in share count by 44% since the end of 2015 [1] - The stock reached new all-time highs last month but has since pulled back nearly $50 without a specific reason, indicating a potential buying opportunity [1] - L1 Capital has reduced its investment in HCA Healthcare due to strong share price appreciation, although it remains a retained investment, no longer a top 10 holding [2] Group 2 - The market has previously reacted pessimistically to potential regulatory developments affecting HCA, creating opportunities for investment at attractive price levels [2] - Current expectations for operating conditions are more balanced, and the share price has increased significantly, leading to a less favorable risk-adjusted return potential from the current price [2] - There is a belief that certain AI stocks may offer greater upside potential and carry less downside risk compared to HCA [2]